WPRIM Management System> DCMS> Journal of Clinical Hepatology> 2016> 32> 2

Volume: 32 Issue: 2

1. Work-up for diagnosis and treatment of liver cirrhosis: convention and development Page:201—202
2. Retrospects and prospects of transjugular intrahepatic portosystemic shunt in China Page:230—233
3. Advances in transjugular intrahepatic portosystemic shunt and its application in treatment of cirrhotic portal hypertension Page:234—237
4. Prevention and treatment of complications after transjugular intrahepatic portosystemic shunt Page:238—241
5. Individualized treatment of liver cirrhosis and esophageal and gastric varices from the perspective of Baveno Ⅳ Page:242—244
6. Research advances in non-cirrhotic portal hypertension Page:245—249
7. Current status and perspectives of surgical treatment of portal hypertension Page:250—253
8. Effect of antiviral therapy on prognosis of patients with decompensated hepatitis B cirrhosis undergoing transjugular intrahepatic portosystemic shunt Page:254—258
9. Therapeutic effect and safety of transjugular intrahepatic portosystemic shunt in patients with primary biliary cirrhosis and portal hypertension Page:259—263
10. Clinical manifestations of portal vein thrombosis and related risk factors in patients with liver cirrhosis Page:275—278
11. Risk factors for antibiotic prophylaxis failure in patients with liver cirrhosis and upper gastrointestinal bleeding Page:288—291
12. Accuracy of FibroScan for diagnosis of primary liver cancer: a Meta-analysis Page:312—316
13. Effects of two methods for hepatic vascular occlusion in resection of giant hepatic hemangioma Page:317—319
14. Effect of continuous blood purification in treatment of patients with severe acute pancreatitis and multiple organ dysfunction syndrome Page:320—323
15. Changes in serum levels of M30, M65, and IL-17 and their clinical significance in patients with acute pancreatitis Page:329—332
16. Effect of Blumgart anastomosis in prevention and treatment of pancreatic fistula after pancreaticoduodenectomy Page:333—336
17. Expression and roles of poly(ADP-ribose) polymerase-1 and caspase-3 in pancreatic cancer and adjacent tissues Page:337—341
18. Treatment and prevention strategies to complications of transjugular intrahepatic portosystemic shunt Page:354—357
19. Research advances in portal hypertensive gastropathy Page:358—360
20. Research advances in association between regulatory T cells and hepatitis B virus infection Page:361—365
21. Research advances in hepatitis B virus-associated glomerulonephritis Page:366—369
22. Current studies of novel drugs against hepatitis B virus in clinical trials Page:370—373
23. Research advances in methods for determination of tumor boundary in hepatectomy Page:374—377
24. Research advances in non-hormonal therapies for autoimmune hepatitis Page:378—381
25. Research advances in the pathogenesis of drug-induced liver injury Page:382—385
26. Advances in clinical research on liver disease during pregnancy Page:386—389
27. Role of ADAMTS13 in diagnosis and pathogenesis of liver diseases Page:390—392
28. Research progress in association between interleukin-23 and liver diseases Page:393—396
29. The role of hepatocyte nuclear factor 4 alpha in development and progression of liver diseases Page:397—403

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.